Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Thyroxine (T4) may help heal skin wounds by promoting new skin and blood vessel growth.

Mathematical modeling can improve regenerative medicine by predicting biological processes and optimizing therapy development.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The study concluded that hair growth in mice is regulated by a stable interaction between skin cell types, and disrupting this can cause hair loss.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

Long-COVID causes more health issues after COVID-19, varying by age, sex, and infection wave.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Niacinamide does not promote hair growth.

AI improves biomaterial design by making it faster, cheaper, and more effective for personalized medicine.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Higher cannabis exposure may lead to increased hair loss.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

GLP-1RA therapy may increase the risk of hair loss.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

AI in heart scans improves diagnosis and treatment but has risks like misdiagnosis and high costs.

Long-COVID has diverse, long-term health impacts, especially in young people.

Computational methods can speed up and improve the development and safety of herbal drugs.

The hexosamine pathway helps protect skin cells from stress and may improve skin and hair health.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.